EZH2 and cholangiocarcinoma: As discovered by our findings, knockdown of the SNHG1 lowered the binding of EZH2 as well as H3K27 trimethylation levels all through the promoter of the CDKN1A, resulting in the augmented level of the CDKN1A that was capable of decelerating the growth of CCA.